Mitchell & Pahl Private Wealth, LLC Abb Vie Inc. Transaction History
Mitchell & Pahl Private Wealth, LLC
- $206 Million
- Q4 2024
A detailed history of Mitchell & Pahl Private Wealth, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Mitchell & Pahl Private Wealth, LLC holds 16,378 shares of ABBV stock, worth $2.8 Million. This represents 1.41% of its overall portfolio holdings.
Number of Shares
16,378
Previous 15,790
3.72%
Holding current value
$2.8 Million
Previous $3.12 Million
6.67%
% of portfolio
1.41%
Previous 1.49%
Shares
17 transactions
Others Institutions Holding ABBV
# of Institutions
3,869Shares Held
1.25BCall Options Held
16.8MPut Options Held
12.2M-
Vanguard Group Inc Valley Forge, PA172MShares$29.3 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$23.3 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$13.5 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.3MShares$8.93 Billion0.85% of portfolio
-
Morgan Stanley New York, NY38.7MShares$6.61 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $302B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...